chasewnelson on Nostr: 2⃣MOLNUPIRAVIR (MOV). #Merck obtained emergency approval for MOV in December 2021 ...
2⃣MOLNUPIRAVIR (MOV). #Merck obtained emergency approval for MOV in December 2021 — just barely the first oral antiviral against COVID-19.
But MOV works by causing viral mutations, the raw material for new variants of concern. 5/12
Published at
2023-06-15 04:14:59Event JSON
{
"id": "9d64419134fc6099ce5676da65b4f6afca02b97d9e4aa01cd80352072b37c150",
"pubkey": "4f8f5b238f242789eaeb4e4198fa7e73358ecafb71a18737b22237aff9e684c5",
"created_at": 1686802499,
"kind": 1,
"tags": [
[
"e",
"b47bb9332f1a047fd45fdc045b7807aa170ea26897667467c157625c86de979c"
],
[
"e",
"60fd20ccf8b548b5b5288c6199ecca8dcf2441171700fdd63059f783f94de25a"
],
[
"imeta",
"url https://nostr.build/i/346436bde46cca4df7aad3abe4dc07107fcb59a74efeb4d0778f41d807f5178e.jpg",
"blurhash eQS$iaa}xvoft8t6a}j[fPfR.AofM{jsRit7j?azbIjsD%WBxZa~t7",
"dim 950x664"
],
[
"t",
"merck"
]
],
"content": "2⃣MOLNUPIRAVIR (MOV). #Merck obtained emergency approval for MOV in December 2021 — just barely the first oral antiviral against COVID-19.\n\nBut MOV works by causing viral mutations, the raw material for new variants of concern. 5/12 https://nostr.build/i/346436bde46cca4df7aad3abe4dc07107fcb59a74efeb4d0778f41d807f5178e.jpg ",
"sig": "a5bd5808e7e3095653a03185628179364be92dcb20bad057184a6ffe31e9e2e748d319b2e0fe022df46aa256123d2d14080a61f20d856b61a9a3d381ef78a290"
}
